95 related articles for article (PubMed ID: 30221699)
1. miR‑501‑3p sensitizes glioma cells to cisplatin by targeting MYCN.
Zhang CG; Yang F; Li YH; Sun Y; Liu XJ; Wu X
Mol Med Rep; 2018 Nov; 18(5):4747-4752. PubMed ID: 30221699
[TBL] [Abstract][Full Text] [Related]
2. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
3. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
[TBL] [Abstract][Full Text] [Related]
4. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
[TBL] [Abstract][Full Text] [Related]
5. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
6. miRNA‑328 overexpression confers cisplatin resistance in non‑small cell lung cancer via targeting of PTEN.
Wang C; Wang S; Ma F; Zhang W
Mol Med Rep; 2018 Nov; 18(5):4563-4570. PubMed ID: 30221716
[TBL] [Abstract][Full Text] [Related]
7. miR‑501‑3p promotes colorectal cancer progression via activation of Wnt/β‑catenin signaling.
Wu F; Xing T; Gao X; Liu F
Int J Oncol; 2019 Sep; 55(3):671-683. PubMed ID: 31364752
[TBL] [Abstract][Full Text] [Related]
8. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
9. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
[TBL] [Abstract][Full Text] [Related]
10. miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.
Liu J; Bi J; Li Z; Li Z; Liu X; Kong C
Int J Mol Med; 2018 Mar; 41(3):1765-1773. PubMed ID: 29328435
[TBL] [Abstract][Full Text] [Related]
11. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
12. MiR-29b inhibits the growth of glioma via MYCN dependent way.
Sun G; Lu J; Zhang C; You R; Shi L; Jiang N; Nie D; Zhu J; Li M; Guo J
Oncotarget; 2017 Jul; 8(28):45224-45233. PubMed ID: 28423357
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
15. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
16. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
17. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
18. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
19. Voltage‑gated K+ channel blocker quinidine inhibits proliferation and induces apoptosis by regulating expression of microRNAs in human glioma U87‑MG cells.
Ru Q; Tian X; Pi MS; Chen L; Yue K; Xiong Q; Ma BM; Li CY
Int J Oncol; 2015 Feb; 46(2):833-40. PubMed ID: 25420507
[TBL] [Abstract][Full Text] [Related]
20. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
